Low-cost stock markets with "streamlined" regulatory constraints for small-to-medium sized companies again are all the rage in Europe, with other bourses seeking to emulate the success of London's AIM. But while the re-emergence of lightly...

As the sign says, "objects in the rear view mirror are closer than they appear." On the heels of last week's positive Phase III data for Avastin as first-line therapy for metastatic breast cancer, and...

Optimists should be cheering the fact that investors continued to bid up biotech during the final week in front of the American Society of Clinical Oncology (ASCO) meeting, which opened in Chicago last Friday, even...

Deutsche Boerse said it will discontinue both the Neuer Markt and SMAX of the Frankfurt Stock Exchange by the end of 2003 in a move to restore investor confidence in small- and medium-sized high tech...

'The great tragedy of science - the slaying of a beautiful hypothesis by an ugly fact.' - Biologist Thomas Henry Huxley It was hard to ignore the level of swagger and hubris among company executives at the...

Germany's biotech stocks have been trapped in the Neuer Markt meltdown since the end of July last year, with 10 biotech listings tracked by BioCentury falling some 70% in aggregate through last week. The meltdown,...

London & the Continent Stifling an equity culture OXFORD - If the focus of the U.S. equity markets this year has been on the positive effects of the human genome project and the unprecedented fundraising activity,...

At first blush, the five U.S. IPOs that have priced in the last three weeks have not lived up to their expectations. The group has raised $273 million, but in doing so has left $203...

MCHM started trading on the Frankfurt Stock Exchange. BC Staff...